Actively Recruiting
Evaluating Biomarkers NSE and NFL as Predictors of Silent Cerebral Infarcts in Patients Undergoing High-Risk Transcatheter Procedures
Led by Aristotle University Of Thessaloniki · Updated on 2026-09-28
100
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the prognostic role of biomarkers neuron specific enolase NSE and neurofilament light chains NFLs in patients undergoing transcatheter interventions that carry a high risk of silent cerebral infarctions SCIs. These SCIs, which often go unnoticed, are linked to neurological deficits, cognitive impairment, increased mortality, and a higher risk of dementia. The study aims to determine if levels of these biomarkers can predict the development of SCIs and long-term cognitive decline. This is a prospective observational study including patients with carotid artery disease undergoing transcatheter revascularization and patients with cardiac arrhythmias undergoing transcatheter ablation procedures. Blood samples will be collected 24 hours before and 24 hours after the interventions to measure NSE and NFLs. Brain MRI scans will be performed at the same time points to detect new SCIs. Participants will also complete neurological assessments using the Mini Mental State Examination MMSE and Montreal Cognitive Assessment MoCA questionnaires 24 hours before, 24 hours after, and 6 months after the interventions. The study will analyze the association between biomarker levels and new SCIs on MRI, as well as the correlation with cognitive changes over time. The findings aim to support the development of tools for better management of patients at risk of SCIs.
CONDITIONS
Brief Title
Biomarkers as Prognostic Factors of Silent, Cerebral Infarctions in Patients Undergoing High-thromboembolic-risk Transcatheter Interventions
Research Team
S
Stergios Tzikas, Associate Professor of Cardiology
A
Alexandros Evangeliou, Resident fo Cardiology
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here